ACTIVE

22 Invest

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result47,3 k €+204,6 %over 1 year

Gross margin359,9 k €+63,2 %over 1 year

Equity482,8 k €+10,9 %over 1 year

Workforce0,0 ETP

Identity

Source · BCE/KBO

22 Invest is a Private limited company incorporated in 2020. Its main activity is: Buying and selling of own real estate. Its registered office is in Antwerpen.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0741.573.908
Incorporation: 15/01/2020
Legal form: Private limited company
Registered office: Mediaplein 1
2018 Antwerpen · FlandreSee on map
Contributed capital: 330 000,00 €
Latest accounts: 31/12/2025
Average workforce: 0,0 ETP

Activities (NACE)

68100Buying and selling of own real estate· main 68110Buying and selling of own real estate

Signals

ProfitableGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 6 filings

Trend over 5 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	359,9 k €	+63.2%	220,6 k €	-9.8%	244,6 k €	+1740%	13,3 k €	-95.7%	307,3 k €
EBITDA	326,4 k €	+49.9%	217,8 k €	-10.6%	243,5 k €	+1877%	12,3 k €	-96.0%	306,8 k €
Operating result	321,4 k €	+48.7%	216,2 k €	-10.1%	240,5 k €	+2094%	11 k €	-96.4%	306 k €
Net result	47,3 k €	+205%	15,5 k €	-74.4%	60,6 k €	+161%	-99,6 k €	-166%	150,9 k €
Balance sheet
Equity	482,8 k €	+10.9%	435,5 k €	+3.7%	420 k €	+16.9%	359,4 k €	-21.7%	459 k €
Total assets	13,8 M €	-13.9%	16,1 M €	-18.9%	19,8 M €	+65.2%	12 M €	+55.1%	7,7 M €
Cash	452,5 k €	+241%	132,5 k €	+598%	19 k €	-30.6%	27,4 k €	+134%	11,7 k €
Debts	12,7 M €	-18.9%	15,6 M €	-18.9%	19,3 M €	+65.5%	11,6 M €	+59.9%	7,3 M €
Other
Workforce	0,0 ETP		0,0 ETP		–		–		–

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 4 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Stélina Invest0739.524.931Represented by Lien Van Mechelen	Directorsince 21/10/2025
Vercam Trade0774.887.270Represented by Stéphane Verbeeck	Directorsince 21/10/2025
Contrarian0675.425.054Represented by Björn Dillien	Directorsince 15/01/2020

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CDC Design0643.814.239Represented by Caroline De Cuyper	Director15/01/2020 → 08/02/2022
Lien Van Mechelen	Director15/01/2020 → 2024 accounts
MAXS0555.912.047Represented by Annick VAN MULLEM	Director15/01/2020 → 2023 accounts
Stephane Verbeeck	Director15/01/2020 → 2024 accounts

Other companies at this address

Mediaplein 1 2018 Antwerpen

Company	CBE no.
1889 Antwerp● Active	0781.806.835
22 Capitall● Active	1013.107.194
22 Construct● Active	0758.922.456
22 Estate● Active	1002.200.931
A & D II● Active	0436.801.391
A place● Active	1012.246.369
Arenberg24● Active	0792.712.209
BINOFIN● Active	1010.960.724
Bredestraat SPV● Active	1037.354.226
CIM - GROUP● Active	0435.995.006
DEPA NASSEN● Active	0835.923.729
DPG FAMILY FOUNDATION● Active	1011.648.533
DPG Media● Active	0432.306.234
DPG Media Group● Active	0440.653.281
EPIFIN● Active	0863.578.132
FastFine Belgium● Active	0763.799.873
Gesu● Active	0727.415.767
GOMMA● Active	0892.019.720
Independer.be● Active	0741.664.275
Klapdorp Estate● Active	0791.282.052

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	15/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	15/09/2026	14/10/2025	06/08/2024	08/08/2023	05/09/2022	01/07/2021
General meeting	04/09/2026	10/10/2025	26/06/2024	15/07/2023	20/08/2022	02/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 6 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	04/09/2026	15/09/2026	Dutch	PDF
Abridged model	31/12/2024	10/10/2025	14/10/2025	Dutch	PDF
Abridged model	31/12/2023	26/06/2024	06/08/2024	Dutch	PDF
Abridged model	31/12/2022	15/07/2023	08/08/2023	Dutch	PDF
Abridged model	31/12/2021	20/08/2022	05/09/2022	Dutch	PDF
Micro model	31/12/2020	02/06/2021	01/07/2021	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 4 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Stélina Invest0739.524.931Represented by Lien Van Mechelen	Directorsince 21/10/2025
Vercam Trade0774.887.270Represented by Stéphane Verbeeck	Directorsince 21/10/2025
Contrarian0675.425.054Represented by Björn Dillien	Directorsince 15/01/2020

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CDC Design0643.814.239Represented by Caroline De Cuyper	Director15/01/2020 → 08/02/2022
Lien Van Mechelen	Director15/01/2020 → 2024 accounts
MAXS0555.912.047Represented by Annick VAN MULLEM	Director15/01/2020 → 2023 accounts
Stephane Verbeeck	Director15/01/2020 → 2024 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates10/11/2025
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/10/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates09/03/2022
ONTSLAGEN - BENOEMINGEN
PDF
Registered office01/10/2020
MAATSCHAPPELIJKE ZETEL
PDF
Other17/01/2020
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings5 filings

Mandates

Stélina Invest

Vercam Trade

Contrarian

MAXS

CDC Design

Stephane Verbeeck

Lien Van Mechelen

2020202120222023202420252026

22 Invest

Mediaplein 1, 2018 Antwerp-2018Vijfhoekstraat 24, 2000 Antwerp

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Mediaplein 1, 2018 Antwerp-2018Current	accounts 2025	Accounts 2025 · 2026-00517234
Vijfhoekstraat 24, 2600 Berchem (Antwerp)	accounts 2024	Accounts 2024 · 2025-00541716
Vijfhoekstraat 24, 2000 Antwerp	accounts 2021 → 2023	Accounts 2023 · 2024-00331929

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
22 InvestCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00517234

Events

2025
Annual accounts 202547,3 k €↑
2024
Annual accounts 202415,5 k €↓
2023
Annual accounts 202360,6 k €↑
2022
Annual accounts 2022-99,6 k €↓
2021
Annual accounts 2021150,9 k €
15/01/2020
IncorporationPrivate limited company

22 Invest

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events